标题
Cystic Fibrosis Airway Microbiome: Overturning the Old, Opening the Way for the New
作者
关键词
-
出版物
JOURNAL OF BACTERIOLOGY
Volume 200, Issue 4, Pages -
出版商
American Society for Microbiology
发表日期
2017-10-30
DOI
10.1128/jb.00561-17
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Concordance between upper and lower airway microbiota in infants with cystic fibrosis
- (2017) Sabine M.P.J. Prevaes et al. EUROPEAN RESPIRATORY JOURNAL
- The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
- (2017) Alya A. Heirali et al. Microbiome
- Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
- (2017) Rounak Feigelman et al. Microbiome
- Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation
- (2017) Linh Do Ngoc Nguyen et al. PLoS One
- Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis
- (2017) Fiona J. Whelan et al. PLoS One
- Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes
- (2016) D. H. Limoli et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Treatment of pulmonary exacerbations in cystic fibrosis – could do better?
- (2016) Alan Smyth Paediatric Respiratory Reviews
- Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease
- (2016) Deborah A. Hogan et al. PLoS One
- The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway
- (2015) Bojana Mirković et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- New Inhaled Antimicrobial Formulations for Use in the Cystic Fibrosis Patient Population
- (2015) Christopher T. Campbell et al. ANNALS OF PHARMACOTHERAPY
- Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs
- (2015) Peter Jorth et al. Cell Host & Microbe
- Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis
- (2015) Katherine M. Langan et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome
- (2015) Robert A Quinn et al. ISME Journal
- Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention
- (2015) Leah Cuthbertson et al. ISME Journal
- Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis
- (2015) William G. Flight et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosis
- (2015) Jiangchao Zhao et al. Journal of Cystic Fibrosis
- The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
- (2015) Lisa A Carmody et al. Microbiome
- Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization
- (2015) Marlène Keravec et al. SpringerPlus
- Lung microbiota across age and disease stage in cystic fibrosis
- (2015) Bryan Coburn et al. Scientific Reports
- Infections in Patients with Cystic Fibrosis
- (2014) Peter H. Gilligan CLINICS IN LABORATORY MEDICINE
- Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics
- (2014) D. J. Smith et al. EUROPEAN RESPIRATORY JOURNAL
- Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model
- (2014) P Tappenden et al. HEALTH TECHNOLOGY ASSESSMENT
- Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis
- (2014) Laura J Sherrard et al. LANCET
- Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis
- (2014) Henryk Mazurek et al. PEDIATRIC PULMONOLOGY
- Biogeochemical Forces Shape the Composition and Physiology of Polymicrobial Communities in the Cystic Fibrosis Lung
- (2014) R. A. Quinn et al. mBio
- The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention
- (2014) Thomas H Hampton et al. Microbiome
- Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis
- (2014) Sven D Willger et al. Microbiome
- Clinical Insights from Metagenomic Analysis of Sputum Samples from Patients with Cystic Fibrosis
- (2013) Y. W. Lim et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis
- (2013) D.W. Reid et al. Journal of Cystic Fibrosis
- Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
- (2013) Edith T. Zemanick et al. PLoS One
- Rapid 16S rRNA Next-Generation Sequencing of Polymicrobial Clinical Samples for Diagnosis of Complex Bacterial Infections
- (2013) Stephen J. Salipante et al. PLoS One
- The Cystic Fibrosis Airway Microbiome
- (2013) S. V. Lynch et al. Cold Spring Harbor Perspectives in Medicine
- Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation
- (2013) Katherine E Price et al. Microbiome
- Does the ΔF508-CFTR mutation induce a proinflammatory response in human airway epithelial cells?
- (2012) Thomas H. Hampton et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells
- (2012) Q. Yu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevalence of Streptococci and Increased Polymicrobial Diversity Associated with Cystic Fibrosis Patient Stability
- (2012) L. M. Filkins et al. JOURNAL OF BACTERIOLOGY
- Epoxide-Mediated CifR Repression of cif Gene Expression Utilizes Two Binding Sites in Pseudomonas aeruginosa
- (2012) A. E. Ballok et al. JOURNAL OF BACTERIOLOGY
- The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations
- (2012) Anthony A. Fodor et al. PLoS One
- Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota
- (2012) A. F. Goddard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Decade-long bacterial community dynamics in cystic fibrosis airways
- (2012) J. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal LectureThis article is based on a presentation by Dr. Christopher Sibley at the 60th Annual Meeting of the Canadian Society of Microbiologists in Hamilton, Ontario, on 15 June 2010. Dr. Sibley was the recipient of the 2010 Cangene Gold Medal as the Canadian Graduate Student Microbiologist of the Year, an annual award sponsored by Cangene Corporation intended to recognize excellence in graduate research.
- (2011) Christopher D. Sibley et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Pulmonary exacerbations in cystic fibrosis
- (2011) Antine E. Stenbit et al. CURRENT OPINION IN PULMONARY MEDICINE
- The microorganisms in chronically infected end-stage and non-end-stage cystic fibrosis patients
- (2011) Vibeke B. Rudkjøbing et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- True Microbiota Involved in Chronic Lung Infection of Cystic Fibrosis Patients Found by Culturing and 16S rRNA Gene Analysis
- (2011) V. B. Rudkjobing et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa
- (2011) C.E. Wainwright et al. Journal of Cystic Fibrosis
- Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis
- (2011) M. M. Tunney et al. THORAX
- The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples
- (2010) G.B. Rogers et al. CLINICAL MICROBIOLOGY AND INFECTION
- Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine
- (2010) J Stuart Elborn et al. EXPERT OPINION ON PHARMACOTHERAPY
- Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial
- (2010) Michael W. Konstan et al. Journal of Cystic Fibrosis
- McKay agar enables routine quantification of the 'Streptococcus milleri' group in cystic fibrosis patients
- (2010) C. D. Sibley et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
- (2010) Michael J. Cox et al. PLoS One
- Respiratory Care of the Hospitalized Patient With Cystic Fibrosis
- (2010) Thomas J Newton Respiratory Care
- Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
- (2009) George Z. Retsch-Bogart et al. CHEST
- Pseudomonas aeruginosabiofilms in the respiratory tract of cystic fibrosis patients
- (2009) Thomas Bjarnsholt et al. PEDIATRIC PULMONOLOGY
- Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis
- (2008) Michael M. Tunney et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients
- (2008) C. D. Sibley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started